Print

IAVI B001

A Phase I placebo-controlled, double-blinded (in terms of vaccine or placebo), randomized dose-escalation trial to evaluate the safety and immunogenicity of Ad35-GRIN/ENV HIV Vaccine in healthy adult volunteers.

Trial Details:

I Completed
University of Rochester Medical Center, International AIDS Vaccine Initiative (IAVI) March 12, 2009
Ad35-GRIN/ENV Ad35 Gag, RV, integrase, nef A (GRIN) and env A
Ad35-GRIN/ENV Viral Vector - Adeno
Ad35-GRIN/ENV Viral Vector - Adeno
USA 56
NCT00851383
http://www.clinicaltrials.gov/ct2/show/NCT00851383?term=iavi+b001&rank=1